1. Home
  2. JRSH vs MAIA Comparison

JRSH vs MAIA Comparison

Compare JRSH & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$6.32

Market Cap

68.8M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.10

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JRSH
MAIA
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
69.2M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
JRSH
MAIA
Price
$6.32
$1.10
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.50
★ $12.00
AVG Volume (30 Days)
94.8K
★ 564.0K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
★ 485.71
33.33
EPS
★ 0.13
N/A
Revenue
★ $166,263,870.00
N/A
Revenue This Year
$14.07
N/A
Revenue Next Year
$7.46
N/A
P/E Ratio
$48.88
★ N/A
Revenue Growth
★ 14.03
N/A
52 Week Low
$2.85
$0.87
52 Week High
$6.67
$3.19

Technical Indicators

Market Signals
Indicator
JRSH
MAIA
Relative Strength Index (RSI) 63.88 32.19
Support Level $3.11 N/A
Resistance Level N/A $1.47
Average True Range (ATR) 0.26 0.05
MACD 0.01 -0.01
Stochastic Oscillator 69.57 11.11

Price Performance

Historical Comparison
JRSH
MAIA

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: